Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Aug 4;289(6440):289. doi: 10.1136/bmj.289.6440.289

Metformin and glibenclamide: comparative risks.

I W Campbell
PMCID: PMC1442167  PMID: 6430443

Full text

PDF

Page 289

289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asplund K., Wiholm B. E., Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia. 1983 Jun;24(6):412–417. doi: 10.1007/BF00257338. [DOI] [PubMed] [Google Scholar]
  2. Hermann L. S., Magnusson S., Möller B., Casey C., Tucker G. T., Woods H. F. Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function. Acta Med Scand. 1981;209(6):519–520. doi: 10.1111/j.0954-6820.1981.tb11639.x. [DOI] [PubMed] [Google Scholar]
  3. Lucis O. J. The status of metformin in Canada. Can Med Assoc J. 1983 Jan 1;128(1):24–26. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES